Latest Antimalarial drug Stories
Researchers are a step closer to developing new antimalarial drugs after discovering the normal function of a set of proteins related to the malaria parasite protein, which causes resistance to the front-line drug chloroquine.
Johns Hopkins Scientists Find a Source of Nonallergic Itch.
LONDON, Dec. 14 /PRNewswire-FirstCall/ -- A new solution developed by IBM (NYSE: IBM), Novartis and Vodafone with the Roll Back Malaria Partnership, is helping to save lives using everyday technology to improve the availability of anti-malarial drugs in remote areas of Tanzania.
WASHINGTON, Nov. 19 /PRNewswire/ -- Evidence of resistance to the antimalarial drug artemisinin and its derivatives threatens efforts to control malaria in Southeast Asia, and experts fear artemisinin resistance may spread from the Thailand-Cambodia border to affect other malaria endemic countries.
Top scientists reveal the latest innovations in genetically modified mosquitoes, new diagnostic tests and mapping mosquito migrations.
ACTwatch, a research project led by PSI, in collaboration with the London School of Hygiene and Tropical Medicine, released evidence today that indicates that artemisinin combination therapy, the most effective medicines for treating malaria, continue to have a significantly low presence on the market among populations considered to be most at risk.
Scientists at LSTM have developed a tool to support the development of appropriate age-based dosing regimens for malaria drugs.
BARCELONA, Spain, September 17 /PRNewswire/ -- A third (30%) of malaria cases can be avoided in African infants using a safe, affordable and simple tool called Intermittent Preventive Treatment of malaria in Infants (IPTi) with the medicine sulphadoxine-pyrimethamine (SP), which can be delivered alongside existing childhood vaccination programmes.(i) Results of a meta-analysis examining six clinical trials in Africa for the malaria intervention which the World Health Organization already...
A new study in Bangladesh suggests tigecycline -- the first member of a new class of antibiotics -- might be effective against multi-drug-resistant malaria. Researchers said tigecycline shows significant anti-malarial activity on its own and can be administered in combination with traditional anti-malarial drugs. The increasing drug resistance of Plasmodium falciparum, one of the parasites that cause malaria, has resulted in the search for new anti-malarial therapies.
- An imitative word; an onomatopoetic word.